Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-16-137607

SVP & Chief Scientific Officer sold 1,336 shares at $17.56 ($23,460)

From the SEC's structured data for this filing

Trades in this filing

Doberstein Stephen K · SVP & Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-08-16 Sale : show line 1 in the form −1,336 $17.56 $23,460 18,935 D
Open-market sales · 1,336 sh · avg $17.56 · $23,460
Loading xslF345X03/doc4.xml…